{"id":"https://openalex.org/W3043082495","doi":"https://doi.org/10.1007/s10549-020-05755-7","title":"Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2\u2212 advanced breast cancer (PALOMA-1, TRIO-18)","display_name":"Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2\u2212 advanced breast cancer (PALOMA-1, TRIO-18)","publication_year":2020,"publication_date":"2020-07-18","ids":{"openalex":"https://openalex.org/W3043082495","doi":"https://doi.org/10.1007/s10549-020-05755-7","mag":"3043082495","pmid":"https://pubmed.ncbi.nlm.nih.gov/32683565","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7383036"},"language":"en","primary_location":{"id":"doi:10.1007/s10549-020-05755-7","doi":"https://doi.org/10.1007/s10549-020-05755-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10549-020-05755-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10549-020-05755-7.pdf","source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s10549-020-05755-7.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073989429","display_name":"Richard S. Finn","orcid":"https://orcid.org/0000-0003-2494-2126","observed_orcids":["https://orcid.org/0000-0003-2494-2126"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard S. Finn","raw_affiliation_strings":["David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, USA. RFinn@mednet.ucla.edu","David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-2494-2126","affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, USA. RFinn@mednet.ucla.edu","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073658868","display_name":"Katalin Bo\u00e9r","orcid":"https://orcid.org/0000-0002-5101-7289","observed_orcids":["https://orcid.org/0000-0002-5101-7289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katalin Boer","raw_affiliation_strings":["Onkologia, Szent Margit Korhaz, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Onkologia, Szent Margit Korhaz, Budapest, Hungary","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019547742","display_name":"Igor Bondarenko","orcid":"https://orcid.org/0000-0002-7071-2471","observed_orcids":["https://orcid.org/0000-0002-7071-2471"]},"institutions":[{"id":"https://openalex.org/I905458539","display_name":"Dnipro State Medical University","ror":"https://ror.org/0469ncz24","country_code":"UA","type":"healthcare","lineage":["https://openalex.org/I905458539"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Igor Bondarenko","raw_affiliation_strings":["Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine","institution_ids":["https://openalex.org/I905458539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085324127","display_name":"Ravindranath Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133297","display_name":"Comprehensive Blood & Cancer Center","ror":"https://ror.org/02vz7hv03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210133297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravindranath Patel","raw_affiliation_strings":["Comprehensive Blood and Cancer Center, Bakersfield, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Blood and Cancer Center, Bakersfield, CA, USA","institution_ids":["https://openalex.org/I4210133297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074615797","display_name":"Tam\u00e1s Pint\u00e9r","orcid":"https://orcid.org/0000-0001-7462-9424","observed_orcids":["https://orcid.org/0000-0001-7462-9424"]},"institutions":[{"id":"https://openalex.org/I4210146066","display_name":"Petz Alad\u00e1r Megyei Oktat\u00f3 K\u00f3rh\u00e1z","ror":"https://ror.org/03vqk1b90","country_code":"HU","type":"healthcare","lineage":["https://openalex.org/I4210146066"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Tamas Pinter","raw_affiliation_strings":["Petz Aladar Megyei Oktato Korhaz, Gyor, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Petz Aladar Megyei Oktato Korhaz, Gyor, Hungary","institution_ids":["https://openalex.org/I4210146066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059885667","display_name":"Marcus Schmidt","orcid":"https://orcid.org/0000-0003-1365-2414","observed_orcids":["https://orcid.org/0000-0003-1365-2414"]},"institutions":[{"id":"https://openalex.org/I4210094062","display_name":"University Medical Center of the Johannes Gutenberg University Mainz","ror":"https://ror.org/00q1fsf04","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094062"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marcus Schmidt","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany","institution_ids":["https://openalex.org/I4210094062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071143854","display_name":"Yaroslav V. Shparyk","orcid":"https://orcid.org/0000-0003-2074-6320","observed_orcids":["https://orcid.org/0000-0003-2074-6320"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yaroslav V. Shparyk","raw_affiliation_strings":["Lviv State Oncologic Regional Treatment and Diagnostic Center, Lviv, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lviv State Oncologic Regional Treatment and Diagnostic Center, Lviv, Ukraine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114045876","display_name":"Anu R. Thummala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163348","display_name":"Comprehensive Cancer Centers of Nevada","ror":"https://ror.org/05etxbz89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210163348"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anu Thummala","raw_affiliation_strings":["Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA","institution_ids":["https://openalex.org/I4210163348"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nataliia Voitko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147449","display_name":"Kyiv City Clinical Oncology Center","ror":"https://ror.org/0555ajd25","country_code":"UA","type":"healthcare","lineage":["https://openalex.org/I4210147449"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Nataliia Voitko","raw_affiliation_strings":["Kyiv City Clinical Oncology Center, Kyiv, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyiv City Clinical Oncology Center, Kyiv, Ukraine","institution_ids":["https://openalex.org/I4210147449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090337589","display_name":"Eustratios Bananis","orcid":"https://orcid.org/0000-0001-6553-7114","observed_orcids":["https://orcid.org/0000-0001-6553-7114"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eustratios Bananis","raw_affiliation_strings":["Pfizer Inc, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042491180","display_name":"Lynn McRoy","orcid":"https://orcid.org/0000-0002-0986-5364","observed_orcids":["https://orcid.org/0000-0002-0986-5364"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynn McRoy","raw_affiliation_strings":["Pfizer Inc, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061648315","display_name":"Keith D. Wilner","orcid":"https://orcid.org/0000-0002-2276-7865","observed_orcids":["https://orcid.org/0000-0002-2276-7865"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Wilner","raw_affiliation_strings":["Pfizer Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, San Diego, CA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075134210","display_name":"Xin Huang","orcid":"https://orcid.org/0000-0003-3285-365X","observed_orcids":["https://orcid.org/0000-0003-3285-365X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Huang","raw_affiliation_strings":["Pfizer Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, San Diego, CA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010886287","display_name":"Sindy Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sindy Kim","raw_affiliation_strings":["Pfizer Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, San Diego, CA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":["David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048706345","display_name":"Johannes Ettl","orcid":"https://orcid.org/0000-0003-4754-8447","observed_orcids":["https://orcid.org/0000-0003-4754-8447"]},"institutions":[{"id":"https://openalex.org/I2802619606","display_name":"TUM Klinikum","ror":"https://ror.org/04jc43x05","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]},{"id":"https://openalex.org/I62916508","display_name":"Technical University of Munich","ror":"https://ror.org/02kkvpp62","country_code":"DE","type":"education","lineage":["https://openalex.org/I62916508"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Johannes Ettl","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Klinikum Rechts Der Isar, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Klinikum Rechts Der Isar, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany","institution_ids":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5073989429"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":10.2343,"has_fulltext":true,"cited_by_count":175,"citation_normalized_percentile":{"value":0.98776065,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"183","issue":"2","first_page":"419","last_page":"428"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9129999876022339},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6069999933242798},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9240000247955322},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9100000262260437},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7490000128746033},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8539999723434448},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9169999957084656},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6980000138282776},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.6869999766349792},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.9763818979263306},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9552054405212402},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7562875747680664},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.587715744972229},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5812065005302429},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5577980279922485},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.5058038234710693},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5018994808197021},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5007693767547607},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4481925368309021},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.40573224425315857},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.374941349029541},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35107338428497314},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3498923182487488},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.34168052673339844},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.28376340866088867},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.15685084462165833}],"mesh":[{"descriptor_ui":"D000077289","descriptor_name":"Letrozole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017698","descriptor_name":"Postmenopause","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047628","descriptor_name":"Estrogen Receptor alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1007/s10549-020-05755-7","doi":"https://doi.org/10.1007/s10549-020-05755-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10549-020-05755-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10549-020-05755-7.pdf","source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7383036","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7383036","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Res Treat","raw_type":"Text"},{"id":"pmid:32683565","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32683565","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast cancer research and treatment","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:mediatum.ub.tum.de:node/1575873","doi":null,"is_oa":true,"landing_page_url":"http://mediatum.ub.tum.de/node?id=1575873","pdf_url":null,"source":{"id":"https://openalex.org/S4306400453","display_name":"mediaTUM \u2013 the media and publications repository of the Technical University Munich (Technical University Munich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I62916508","host_organization_name":"Technical University of Munich","host_organization_lineage":["https://openalex.org/I62916508"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"pmh:oai:mediatum.ub.tum.de:node/1616623","doi":null,"is_oa":false,"landing_page_url":"https://mediatum.ub.tum.de/1616623","pdf_url":null,"source":{"id":"https://openalex.org/S4306400453","display_name":"mediaTUM \u2013 the media and publications repository of the Technical University Munich (Technical University Munich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I62916508","host_organization_name":"Technical University of Munich","host_organization_lineage":["https://openalex.org/I62916508"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s10549-020-05755-7","doi":"https://doi.org/10.1007/s10549-020-05755-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10549-020-05755-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10549-020-05755-7.pdf","source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3043082495.pdf","grobid_xml":"https://content.openalex.org/works/W3043082495.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1464936406","https://openalex.org/W1968993577","https://openalex.org/W2135404867","https://openalex.org/W2144790402","https://openalex.org/W2148345265","https://openalex.org/W2154626333","https://openalex.org/W2158679766","https://openalex.org/W2404884142","https://openalex.org/W2478829584","https://openalex.org/W2528767298","https://openalex.org/W2552099557","https://openalex.org/W2620993107","https://openalex.org/W2763875663","https://openalex.org/W2799600909","https://openalex.org/W2804105316","https://openalex.org/W2805575723","https://openalex.org/W2843951495","https://openalex.org/W2884436796","https://openalex.org/W2889646458","https://openalex.org/W2896846857","https://openalex.org/W2908699784","https://openalex.org/W2948069739","https://openalex.org/W2976415870","https://openalex.org/W3133509869"],"related_works":["https://openalex.org/W2624068231","https://openalex.org/W4293083647","https://openalex.org/W2743294916","https://openalex.org/W2908699784","https://openalex.org/W2464376480","https://openalex.org/W2144790402","https://openalex.org/W2619542078","https://openalex.org/W2552099557","https://openalex.org/W2790211645","https://openalex.org/W2804536153"],"abstract_inverted_index":{"PURPOSE:":[0],"Palbociclib":[1,231],"is":[2],"a":[3,237],"cyclin-dependent":[4],"kinase":[5],"4/6":[6],"(CDK4/6)":[7],"inhibitor,":[8],"approved":[9],"in":[10,70,169,214,244],"combination":[11],"with":[12,22,73,93,196],"endocrine":[13],"therapy":[14],"for":[15,157],"the":[16,37,81,139,153,170,215],"treatment":[17,234],"of":[18,133,143,149],"women":[19,72,92],"and":[20,86,128,174,180,204],"men":[21],"hormone":[23],"receptor-positive,":[24],"human":[25],"epidermal":[26],"growth":[27],"factor":[28],"receptor":[29],"2-negative":[30],"advanced":[31],"breast":[32],"cancer":[33],"(HR+/HER2-":[34],"ABC).":[35],"In":[36],"phase":[38],"2,":[39],"open-label,":[40],"PALOMA-1":[41],"trial,":[42],"palbociclib":[43,102,171,197,216],"plus":[44,107,172,198,217,232],"letrozole":[45,52,108,113,173,175,199,201,218,233],"significantly":[46],"prolonged":[47],"progression-free":[48],"survival":[49,84],"(PFS)":[50],"versus":[51],"alone":[53,114,176,202],"(hazard":[54],"ratio,":[55],"0.488;":[56],"95%":[57],"CI":[58,162],"0.319\u20120.748;":[59],"P":[60,164],"=":[61,165],"0.0004;":[62],"median":[63,167,185,245],"PFS,":[64],"20.2":[65],"vs":[66],"10.2":[67],"months,":[68,182,206],"respectively)":[69],"postmenopausal":[71],"estrogen":[74],"receptor-positive":[75],"(ER+)/HER2-":[76],"ABC.":[77],"Here,":[78],"we":[79],"present":[80],"final":[82],"overall":[83],"(OS)":[85],"updated":[87],"safety":[88],"results.":[89],"METHODS:":[90],"Postmenopausal":[91],"ER+/HER2-":[94],"ABC":[95],"were":[96,136],"randomized":[97],"1:1":[98],"to":[99,189,236],"receive":[100],"either":[101],"(125":[103],"mg/day,":[104,110,116],"3/1":[105],"schedule)":[106],"(2.5":[109,115],"continuous)":[111],"or":[112,227],"continuous).":[117],"The":[118,184,208],"primary":[119],"endpoint":[120],"was":[121,159,178,194,220],"investigator-assessed":[122],"PFS;":[123],"secondary":[124],"endpoints":[125],"included":[126],"OS":[127,158,168],"safety.":[129],"RESULTS:":[130],"A":[131],"total":[132],"165":[134],"patients":[135],"randomized.":[137],"At":[138],"data":[140],"cutoff":[141],"date":[142],"December":[144],"30,":[145],"2016":[146],"(median":[147],"duration":[148],"follow-up,":[150],"64.7":[151],"months),":[152],"stratified":[154],"hazard":[155],"ratio":[156],"0.897":[160],"(95%":[161],"0.623-1.294;":[163],"0.281);":[166],"arms":[177],"37.5":[179],"34.5":[181],"respectively.":[183],"time":[186],"from":[187],"randomization":[188],"first":[190],"subsequent":[191],"chemotherapy":[192],"use":[193],"longer":[195],"than":[200],"(26.7":[203],"17.7":[205],"respectively).":[207],"most":[209],"frequently":[210],"reported":[211],"adverse":[212],"event":[213],"arm":[219],"neutropenia":[221],"(any":[222],"grade,":[223],"75%;":[224],"grade":[225],"3":[226],"4,":[228],"59%).":[229],"CONCLUSIONS:":[230],"led":[235],"numerical":[238],"but":[239],"not":[240],"statistically":[241],"significant":[242],"improvement":[243],"OS.":[246],"Pfizer":[247],"Inc":[248],"(NCT00721409).":[249]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":43},{"year":2024,"cited_by_count":41},{"year":2023,"cited_by_count":26},{"year":2022,"cited_by_count":27},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-07-23T00:00:00"}